Display Settings:

Format

Send to:

Choose Destination

    Dermatol Surg. 2004 Feb;30(2 Pt 2):326-33; discussion 333.

    Keratoacanthoma: a clinico-pathologic enigma.

    Schwartz RA.

    Dermatology, New Jersey Medical School, Newark, New Jersey, USA.

    BACKGROUND: Keratoacanthoma (KA) is an extraordinary entity. Once considered a benign neoplasm that resembled a highly malignant one (pseudomalignancy), it is now viewed in an opposite light as a cancer that resembles a benign neoplasm (pseudobenignity). OBJECTIVE: The goal was to delineate the malignant potential of this neoplasm based on the author's experience and a review of recent data and research and to emphasize the KA as a possible part of an autosomal dominant familial cancer syndrome, the Muir-Torre syndrome. METHODS: This is a review of the literature. RESULTS: In this work, the KA is reviewed with recent advances emphasized. CONCLUSION: KA is an abortive malignancy that rarely progresses into an invasive SCC. The KA may serve as a marker for the important autosomal dominant familial cancer syndrome, the Muir-Torre syndrome, as a result of a defective DNA mismatch repair gene.

    PMID: 14871228 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read